Bayer and VUMC Partner to Advance Cardiovascular and Kidney Therapies
The collaboration will focus initially on cardiovascular and kidney diseases, combining Bayer’s drug development expertise with Vanderbilt University Medical Center’s extensive data resources to generate data-driven insights and accelerate the discovery and development of new therapies addressing significant unmet medical needs.
Precision Medicine | 21/01/2026 | By News Bureau
Jacobio Pharma Signs Global Licensing Deal with AstraZeneca for Pan-KRAS Drug
Under the agreement, Jacobio will receive USD 100 million upfront and is eligible for up to USD 1.915 billion in development and commercial milestones, along with tiered royalties on ex-China sales, while AstraZeneca will lead all ex-China development, regulatory and commercial activities for JAB-23E73.
Precision Medicine | 22/12/2025 | By News Bureau
Agilent Launches Biopharma CDx Services Lab to Accelerate Precision Medicine
The BCSL and Agilent’s assay development model will support drug development from early clinical studies through regulatory approval with efficient, flexible, and streamlined companion diagnostic development.
Precision Medicine | 10/09/2024 | By Aishwarya | 728
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy